Skip to main content
Top
Published in: Radiation Oncology 1/2022

Open Access 01-12-2022 | Metastasis | Research

Treatment plan comparison for irradiation of multiple brain metastases with hippocampal avoidance whole brain radiotherapy and simultaneous integrated boost using the Varian Halcyon and the Elekta Synergy platforms

Authors: Johannes Kraft, Stefan Weick, Kathrin Breuer, Paul Lutyj, Klaus Bratengeier, Florian Exner, Anne Richter, Jörg Tamihardja, Dominik Lisowski, Bülent Polat, Michael Flentje

Published in: Radiation Oncology | Issue 1/2022

Login to get access

Excerpt

Around 20–40% of all cancer patients develop brain metastases during their course of disease which is associated with significant morbidity and mortality [1]. Brain metastases mostly occur in patients with lung cancer, breast cancer and melanoma [2]. The incidence generally slightly increased over the last years and especially the number of patients with multiple brain metastases is increasing [3]. The treatment of limited brain metastases is well defined in clinical guidelines and comprises upfront radiosurgery, resection followed by adjuvant radiosurgery/fractionated stereotactic radiotherapy or systemic therapy in cancer with a targetable driver mutation or excellent response to immunotherapy such as melanoma [4]. In contrast, the treatment of patients with multiple brain metastases is more challenging and a clear recommendation is not given within the guidelines [3]. There are two competing major radiotherapy policies for the treatment of multiple brain metastases—whole brain irradiation (WBRT) on the one hand and radiosurgery (SRS) on the other hand. Stereotactic radiotherapy or radiosurgery approaches apply a high dose to the tumor with a steep dose fall off to the surrounding tissue to spare as much as possible healthy brain tissue. Nevertheless, microscopic tumor spread within the brain is more likely with multiple brain metastases which can be drawn from a higher risk of loco-regional (distant brain) failure with SRS in multiple brain metastases [5, 6]. Whole-brain radiotherapy concepts have not been displaced by stereotactic radiotherapy in multiple brain metastases and yield the benefit of treating microscopic metastatic spread. However, the irradiation of the whole brain comes along with a detrimental neurocognitive decline with damaged neural stem cells within the hippocampal being the most relevant cause [7, 8]. Therefore hippocampal radiotherapy techniques have been introduced to spare the stem cells within the hippocampal area [9]. Hippocampus avoidance whole-brain irradiation (HA-WBRT) with simultaneous integrated boost (SIB) is the most sophisticated concept within whole-brain irradiation concepts, where in addition to hippocampal sparing and prophylactic dose to the healthy brain, dose escalation in the gross tumor volume is pursued to improve local control [10]. …
Literature
1.
go back to reference Sul J, Posner JB. Brain metastases: epidemiology and pathophysiology. Cancer Treat Res. 2007;136:1–21.CrossRefPubMed Sul J, Posner JB. Brain metastases: epidemiology and pathophysiology. Cancer Treat Res. 2007;136:1–21.CrossRefPubMed
2.
3.
go back to reference Kraft J, Zindler J, Minniti G, Guckenberger M, Andratschke N. Stereotactic radiosurgery for multiple brain metastases. Curr Treat Options Neurol. 2019;21:6.CrossRefPubMed Kraft J, Zindler J, Minniti G, Guckenberger M, Andratschke N. Stereotactic radiosurgery for multiple brain metastases. Curr Treat Options Neurol. 2019;21:6.CrossRefPubMed
4.
go back to reference Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, et al. Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol. 2022;40:492–516.CrossRefPubMed Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, et al. Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol. 2022;40:492–516.CrossRefPubMed
5.
go back to reference Sawrie SM, Guthrie BL, Spencer SA, Nordal RA, Meredith RF, Markert JM, et al. Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone. Int J Radiat Oncol Biol Phys. 2008;70:181–6.CrossRefPubMed Sawrie SM, Guthrie BL, Spencer SA, Nordal RA, Meredith RF, Markert JM, et al. Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone. Int J Radiat Oncol Biol Phys. 2008;70:181–6.CrossRefPubMed
6.
go back to reference Mizuno T, Takada K, Hasegawa T, Yoshida T, Murotani K, Kobayashi H, et al. Comparison between stereotactic radiosurgery and whole-brain radiotherapy for 10–20 brain metastases from non-small cell lung cancer. Mol Clin Oncol. 2019;10:560–6.PubMedPubMedCentral Mizuno T, Takada K, Hasegawa T, Yoshida T, Murotani K, Kobayashi H, et al. Comparison between stereotactic radiosurgery and whole-brain radiotherapy for 10–20 brain metastases from non-small cell lung cancer. Mol Clin Oncol. 2019;10:560–6.PubMedPubMedCentral
7.
go back to reference Mizumatsu S, Monje ML, Morhardt DR, Rola R, Palmer TD, Fike JR. Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res. 2003;63:4021–7.PubMed Mizumatsu S, Monje ML, Morhardt DR, Rola R, Palmer TD, Fike JR. Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res. 2003;63:4021–7.PubMed
8.
go back to reference Monje ML, Mizumatsu S, Fike JR, Palmer TD. Irradiation induces neural precursor-cell dysfunction. Nat Med. 2002;8:955–62.CrossRefPubMed Monje ML, Mizumatsu S, Fike JR, Palmer TD. Irradiation induces neural precursor-cell dysfunction. Nat Med. 2002;8:955–62.CrossRefPubMed
9.
go back to reference Kazda T, Jancalek R, Pospisil P, Sevela O, Prochazka T, Vrzal M, et al. Why and how to spare the hippocampus during brain radiotherapy: the developing role of hippocampal avoidance in cranial radiotherapy. Radiat Oncol. 2014;9:139.CrossRefPubMedPubMedCentral Kazda T, Jancalek R, Pospisil P, Sevela O, Prochazka T, Vrzal M, et al. Why and how to spare the hippocampus during brain radiotherapy: the developing role of hippocampal avoidance in cranial radiotherapy. Radiat Oncol. 2014;9:139.CrossRefPubMedPubMedCentral
10.
go back to reference Popp I, Rau S, Hintz M, Schneider J, Bilger A, Fennell JT, et al. Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases. Cancer. 2020;126:2694–703.CrossRefPubMed Popp I, Rau S, Hintz M, Schneider J, Bilger A, Fennell JT, et al. Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases. Cancer. 2020;126:2694–703.CrossRefPubMed
11.
go back to reference Hartgerink D, Bruynzeel A, Eekers D, Swinnen A, Hurkmans C, Wiggenraad R, et al. A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4–10 brain metastases. Neurooncol Adv. 2021;3:vdab021.PubMedPubMedCentral Hartgerink D, Bruynzeel A, Eekers D, Swinnen A, Hurkmans C, Wiggenraad R, et al. A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4–10 brain metastases. Neurooncol Adv. 2021;3:vdab021.PubMedPubMedCentral
12.
go back to reference Li J, Ludmir EB, Wang Y, Guha-Thakurta N, McAleer MF, Settle SH Jr, et al. Stereotactic radiosurgery versus whole-brain radiation therapy for patients with 4–15 brain metastases: a phase III randomized controlled trial. Int J Radiat Oncol Biol Phys. 2020;108:21–2.CrossRef Li J, Ludmir EB, Wang Y, Guha-Thakurta N, McAleer MF, Settle SH Jr, et al. Stereotactic radiosurgery versus whole-brain radiation therapy for patients with 4–15 brain metastases: a phase III randomized controlled trial. Int J Radiat Oncol Biol Phys. 2020;108:21–2.CrossRef
13.
go back to reference Gondi V, Pugh SL, Tome WA, Caine C, Corn B, Kanner A, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol. 2014;32:3810–6.CrossRefPubMedPubMedCentral Gondi V, Pugh SL, Tome WA, Caine C, Corn B, Kanner A, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol. 2014;32:3810–6.CrossRefPubMedPubMedCentral
14.
go back to reference Brown PD, Gondi V, Pugh S, Tome WA, Wefel JS, Armstrong TS, et al. Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001. J Clin Oncol. 2020;38:1019–29.CrossRefPubMedPubMedCentral Brown PD, Gondi V, Pugh S, Tome WA, Wefel JS, Armstrong TS, et al. Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001. J Clin Oncol. 2020;38:1019–29.CrossRefPubMedPubMedCentral
15.
go back to reference Rodríguezde Dios N, Couñago F, Murcia-Mejía M, Rico-Oses M, Calvo-Crespo P, Samper P, et al. Randomized phase III trial of prophylactic cranial irradiation with orwithout hippocampal avoidance for small-cell lung cancer (PREMER): aGICOR-GOECP-SEOR study. J Clin Oncol. 2021;39:3118–27.CrossRef Rodríguezde Dios N, Couñago F, Murcia-Mejía M, Rico-Oses M, Calvo-Crespo P, Samper P, et al. Randomized phase III trial of prophylactic cranial irradiation with orwithout hippocampal avoidance for small-cell lung cancer (PREMER): aGICOR-GOECP-SEOR study. J Clin Oncol. 2021;39:3118–27.CrossRef
16.
go back to reference Grosu A-L, Frings L, Bentsalo I, Oehlke O, Brenner F, Bilger A, et al. Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD)—a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG). BMC Cancer. 2020;20:532.CrossRefPubMedPubMedCentral Grosu A-L, Frings L, Bentsalo I, Oehlke O, Brenner F, Bilger A, et al. Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD)—a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG). BMC Cancer. 2020;20:532.CrossRefPubMedPubMedCentral
17.
go back to reference Prescribing R. Intensity-modulated radiation therapy (IMRT): contents. J ICRU. 2010;10:1–3.CrossRef Prescribing R. Intensity-modulated radiation therapy (IMRT): contents. J ICRU. 2010;10:1–3.CrossRef
19.
go back to reference Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363:1665–72.CrossRefPubMed Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363:1665–72.CrossRefPubMed
20.
go back to reference Sperduto PW, Shanley R, Luo X, Andrews D, Werner-Wasik M, Valicenti R, et al. Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1–3 brain metastases; poststratified by the graded prognostic assessment (GPA). Int J Radiat Oncol Biol Phys. 2014;90:526–31.CrossRefPubMedPubMedCentral Sperduto PW, Shanley R, Luo X, Andrews D, Werner-Wasik M, Valicenti R, et al. Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1–3 brain metastases; poststratified by the graded prognostic assessment (GPA). Int J Radiat Oncol Biol Phys. 2014;90:526–31.CrossRefPubMedPubMedCentral
21.
go back to reference Westover KD, Mendel JT, Dan T, Kumar K, Gao A, Pulipparacharuv S, et al. Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer. Neuro Oncol. 2020;22:1831–9.CrossRefPubMedPubMedCentral Westover KD, Mendel JT, Dan T, Kumar K, Gao A, Pulipparacharuv S, et al. Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer. Neuro Oncol. 2020;22:1831–9.CrossRefPubMedPubMedCentral
22.
go back to reference Belderbos JSA, De Ruysscher DKM, De Jaeger K, Koppe F, Lambrecht MLF, Lievens YN, et al. Phase 3 randomized trial of prophylactic cranial irradiation with or without hippocampus avoidance in SCLC (NCT01780675). J Thorac Oncol. 2021;16:840–9.CrossRefPubMed Belderbos JSA, De Ruysscher DKM, De Jaeger K, Koppe F, Lambrecht MLF, Lievens YN, et al. Phase 3 randomized trial of prophylactic cranial irradiation with or without hippocampus avoidance in SCLC (NCT01780675). J Thorac Oncol. 2021;16:840–9.CrossRefPubMed
23.
go back to reference Wolfson AH, Bae K, Komaki R, Meyers C, Movsas B, Le Pechoux C, et al. Primary analysis of a phase II randomized trial radiation therapy oncology group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011;81:77–84.CrossRefPubMed Wolfson AH, Bae K, Komaki R, Meyers C, Movsas B, Le Pechoux C, et al. Primary analysis of a phase II randomized trial radiation therapy oncology group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011;81:77–84.CrossRefPubMed
24.
go back to reference Li T, Irmen P, Liu H, Shi W, Alonso-Basanta M, Zou W, et al. Dosimetric performance and planning/delivery efficiency of a dual-layer stacked and staggered MLC on treating multiple small targets: a planning study based on single-isocenter multi-target stereotactic radiosurgery (SRS) to brain metastases. Front Oncol. 2019;9:7.CrossRefPubMedPubMedCentral Li T, Irmen P, Liu H, Shi W, Alonso-Basanta M, Zou W, et al. Dosimetric performance and planning/delivery efficiency of a dual-layer stacked and staggered MLC on treating multiple small targets: a planning study based on single-isocenter multi-target stereotactic radiosurgery (SRS) to brain metastases. Front Oncol. 2019;9:7.CrossRefPubMedPubMedCentral
25.
go back to reference Yokoyama K, Kurosaki H, Oyoshi H, Miura K, Utsumi N. Plan quality comparison between hippocampus-sparing whole-brain radiotherapy treated with Halcyon and tomotherapy intensity-modulated radiotherapy. Technol Cancer Res Treat. 2022;21:15330338221108528.CrossRefPubMedPubMedCentral Yokoyama K, Kurosaki H, Oyoshi H, Miura K, Utsumi N. Plan quality comparison between hippocampus-sparing whole-brain radiotherapy treated with Halcyon and tomotherapy intensity-modulated radiotherapy. Technol Cancer Res Treat. 2022;21:15330338221108528.CrossRefPubMedPubMedCentral
26.
go back to reference Popp I, Grosu AL, Fennell JT, Fischer M, Baltas D, Wiehle R. Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost-tutorial and efficacy of complete directional hippocampal blocking. Strahlenther Onkol. 2022;198:537–46.CrossRefPubMedPubMedCentral Popp I, Grosu AL, Fennell JT, Fischer M, Baltas D, Wiehle R. Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost-tutorial and efficacy of complete directional hippocampal blocking. Strahlenther Onkol. 2022;198:537–46.CrossRefPubMedPubMedCentral
27.
go back to reference Hsu F, Carolan H, Nichol A, Cao F, Nuraney N, Lee R, et al. Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1–3 brain metastases: a feasibility study using volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys. 2010;76:1480–5.CrossRefPubMed Hsu F, Carolan H, Nichol A, Cao F, Nuraney N, Lee R, et al. Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1–3 brain metastases: a feasibility study using volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys. 2010;76:1480–5.CrossRefPubMed
28.
go back to reference Usui K, Isobe A, Hara N, Muroi T, Sajiki O, Ogawa K, et al. Development of a rotational set-up correction device for stereotactic head radiation therapy: a performance evaluation. J Appl Clin Med Phys. 2019;20:206–12.CrossRefPubMedPubMedCentral Usui K, Isobe A, Hara N, Muroi T, Sajiki O, Ogawa K, et al. Development of a rotational set-up correction device for stereotactic head radiation therapy: a performance evaluation. J Appl Clin Med Phys. 2019;20:206–12.CrossRefPubMedPubMedCentral
29.
go back to reference Sauer O, Wegener S, Schindhelm R. PO-1737 design of a rotatable head fixation for cranial stereotactic treatments. Radiother Oncol. 2021;161:S1460-1.CrossRef Sauer O, Wegener S, Schindhelm R. PO-1737 design of a rotatable head fixation for cranial stereotactic treatments. Radiother Oncol. 2021;161:S1460-1.CrossRef
Metadata
Title
Treatment plan comparison for irradiation of multiple brain metastases with hippocampal avoidance whole brain radiotherapy and simultaneous integrated boost using the Varian Halcyon and the Elekta Synergy platforms
Authors
Johannes Kraft
Stefan Weick
Kathrin Breuer
Paul Lutyj
Klaus Bratengeier
Florian Exner
Anne Richter
Jörg Tamihardja
Dominik Lisowski
Bülent Polat
Michael Flentje
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2022
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-022-02156-6

Other articles of this Issue 1/2022

Radiation Oncology 1/2022 Go to the issue